Australija - anglų - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 137.71 mg/ml (equivalent: amoxicillin, qty 120 mg/ml); potassium clavulanate, quantity: 10.28 mg/ml (equivalent: clavulanic acid, qty 8.58 mg/ml) - suspension, powder for - excipient ingredients: xanthan gum; aspartame; silicon dioxide; colloidal anhydrous silica; carmellose sodium; flavour - augmentin es is indicated in the short term treatment for acute otitis media when susceptible bacterial pathogens (s. pneumoniae. h. influenzae, m. catarrhalis) are suspected or confirmed. appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to augmentin es. however, when there is reason to believe an infection may involve s. pneumoniae with reduced susceptibility to penicillin (penicillin minimum inhibitory concentration (mic) less than or equal to 4 microgram/ml) or any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to augmentin es, should not require the addition of another antibiotic due to the amoxycillin content of augmentin es.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

mylan institutional llc - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil (mmf) for injection is indicated for the prophylaxis of organ rejection, in adult recipients of allogeneic kidney [see clinical studies (14.1)], heart [see clinical studies (14.2)] or liver transplants [see clinical studies (14.3)] , in combination with other immunosuppressants. allergic reactions to mycophenolate mofetil have been observed; therefore, mycophenolate mofetil for injection is contraindicated in patients with a hypersensitivity to mycophenolate mofetil (mmf), mycophenolic acid (mpa) or any component of the drug product. mycophenolate mofetil for injection is contraindicated in patients who are allergic to polysorbate 80 (tween). pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to mycophenolate during pregnancy and those becoming pregnant within 6 weeks of discontinuing mycophenolate mofetil treatment. to report a pregnancy or obtain information about the registry, visit www.mycophenolaterems.com or call

Malaizija - anglų - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - amoxycillin sodium; clavulanic acid -

Jordanija - anglų - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - amoxicillin 1 g, clavulanic acid 0.2 g - 1 g, 0.2 g

Jordanija - anglų - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - amoxicillin 500 mg, potassium clavulanate 100 mg - 500 mg, 100 mg

Airija - anglų - HPRA (Health Products Regulatory Authority)

imbat limited - clavulanate potassium; amoxicillin trihydrate - powder for oral suspension - 400/57 mg/5ml - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Airija - anglų - HPRA (Health Products Regulatory Authority)

b & s healthcare - amoxicillin trihydrate clavulanic acid - powder for oral suspension - 400/57 mg/5ml

Airija - anglų - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - amoxicillin trihydrate, clavulanate potassium - powder for oral suspension - 400/57 mg/5ml - combinations of penicillins, incl. beta-lactamase inhibitors

Airija - anglų - HPRA (Health Products Regulatory Authority)

pco manufacturing - amoxicillin trihydrate, clavulanic acid (in the form of potassium clavulanate) - powder for oral suspension - 400/57 mg/5ml - combinations of penicillins, incl. beta-lactamase inhibitors

Malta - anglų - Medicines Authority

smithkline beecham plc - amoxicillin 400 mg/5ml, clavulanic acid 57 mg/5ml - powder for oral suspension